Company · CIK 0001699031 · SIC 8071 — Services-Medical Laboratories · Nasdaq
GRAIL, Inc. · GRAL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 SForm 4 → | Sep 23, 4:37 pm EDT | Aaron FreidinChief Financial Officer | 4,100 | $93.34 | $382,679 | 248,983 | −1.62% | 10b5-1 |
| Sep 21, 2026 SForm 4 → | Sep 23, 4:37 pm EDT | Joshua J. OfmanChief Executive Officer, Director | 61,452 | $97.74 | $6,006,378 | 362,271 | −14.5% | 10b5-1 |
| Sep 21, 2026 MForm 4 → | Sep 23, 4:37 pm EDT | Joshua J. OfmanChief Executive Officer, Director | 26,452 | $14.00 | $370,328 | 423,723 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 MForm 4 → | Sep 23, 4:37 pm EDT | Joshua J. OfmanChief Executive Officer, Director | 26,452 | — | — | 37,032 | — | 10b5-1 |